-
I don't have time to look up the details, but recently I read a story about a pharmaceutical company getting exclusive rights on the sale of a long existing drug which had become obsolete for one condition for anonther condition. They subsequently made use of this exclusive right by attaching a €120.000 a year price-tag.
-
It seems that Trump has once again drunk the CoolAid of the pharma industry and insists on pissing everyone off as bad as possible.
As Tusk said it: "With a friend like this, who needs enemies?"
